News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The CDMO has appointed Dr. Chi-Chang Wung to the position of director of analytical development, a position in which he will oversee UPM's analytical development group.
Wung previously held senior analytical development and quality control positions at Alkermes, SIGA Technologies, and Asymchem Laboratories.
"I am excited to be a part of this departmental growth at UPM," said Wung. "A strong analytical development group is paramount for a CDMO to be successful. My goals are to lead from a quality by design approach, while mentoring my group to strive for excellence within the analytical organization at UPM."